FDA Sources Sought: Real-World Application for Innovation and Development BPA

Notice ID: FDA-SSN-75F40125Q00029

The U.S. Food and Drug Administration (FDA) is issuing this source sought notice as a means of conducting market research, pursuant to FAR Part 10 Market Research, to identify viable industry parties capable of supporting FDA’s Real-World Application for Innovation and Development (RAPID), enhancement of the current AWS platform, development of new applications prototypes and Proof of Concepts.

Objectives.  Enable the Real-World Application for Innovation and Development (RAPID) Digital AI Platform program to design, develop, deploy prototypes and proof-of-concepts to meet FDA’s mission critical needs.  Expand the RAPID platforms capability building upon the lessons learned and functionality provided by RAPID using innovative architecture to support:

– Continue supporting and maintaining the development of existing databases, technologies, and applications in the RAPID Environment. Provide maintenance support for the FDA RAPID environment and deployed applications in the RAPID environment and support the deployment and enhancement of tools and applications into FDA’s production environments. (i.e., On premise, Cloud Platforms).

• Conduct system upgrades for deployed applications to continually improve the ability for the FDA to meet their mission critical real-time data management and analytical capabilities.
• Continue to establish and maintain the exploration/experimentation sandbox that supports innovation and analytics development in support of regulatory review the development of existing databases, technologies, and applications in the RAPID Environment
• The FDA expects accelerated advancements in various AI and Cloud technologies, both software and hardware, over the next 5 years and are seeking support in enabling the RAPID program to be at the forefront of these advancements.

The anticipated period of performance for this BPA is one (1) base year, plus four (4) option years, beginning on 09/28/2025 and ending on 09/28/2030.

Read more here.

🔊 Listen to Story